Cannabis Research: Harvard Receives $4.5 Million in Donations
Harvard Medical School, a pioneer and model for research in the field, has received a donation of US$4.5 million from an alumnus. The objective: to fund research into the effects of cannabis on the brain and behavior.
The largest donation in history to support cannabis research.
Charles R. Broderick is an alumnus of Harvard University and MIT. Does the name mean nothing to you? Yet he has just made a remarkable gesture: he made a significant donation to support fundamental research into the effects of cannabis on the brain and behavior: in total, Harvard Medical School received US$4.5 million to fund this research.
This Medical School, located in Boston, United States, is one of the most renowned in the world, with international reach and a flattering reputation. The news was announced at the end of April through a communication published on the University's website. It states that Charles R. Broderick, a renowned businessman and alumnus, is behind this donation.
Broderick is a finance specialist and the founder of Uji Capital, a wealth management firm focused on quantitative opportunities in global equity markets. The alumnus identified the growth of the legal cannabis market in Canada as a strategic investment opportunity. This gives even more meaning to his gesture, for the most pragmatic among us.
The total donation amounts to $9 million, with $4.5 million allocated to each institution, but it is above all, to date, the largest donation ever recorded to support independent cannabinoid research.
Destigmatizing the cannabis debate.
Thus, Broderick donated $4.5 million to Harvard Medical School, and the same amount to MIT, the Massachusetts Institute of Technology, as detailed in the press release visible on the university's website:
“I want to destigmatize the cannabis debate – and part of that involves providing facts to the medical community, as well as to the general public,” says Broderick, who stresses that “independent research must form the basis of policy discussions, regardless of whether it’s good for business. Then, we are all working from the same information. We need to replace rhetoric with research.”
He continues: “This gift will allow experts in neuroscience and biomedicine at Harvard Medical School and MIT to conduct research that can help illuminate the biology of cannabinoids, clarify their effects on the human brain, catalyze treatments, and provide factual clinical guidelines for social policies and cannabis regulation.”
